Fusion Pharmaceuticals Inc. Quarterly Return On Equity in % from Q4 2019 to Q2 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q2 2022.
  • Fusion Pharmaceuticals Inc. Return On Equity for the quarter ending June 30, 2022 was -33.9 %, a 43.1% decline year-over-year.
  • Fusion Pharmaceuticals Inc. annual Return On Equity for 2021 was -31.8 %, a 11.7% increase from 2020.
  • Fusion Pharmaceuticals Inc. annual Return On Equity for 2020 was -36 %, a 159% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2022 -33.9 -10.2 -43.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -34.9 -6.21 -21.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -31.8 +4.19 +11.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -28.5 +25.4 +47.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -23.7 +96.9 +80.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -28.7 -98.4 -141% Jan 1, 2021 Mar 31, 2021
Q4 2020 -36 -97.1 -159% Oct 1, 2020 Dec 31, 2020
Q3 2020 -53.9 Jul 1, 2020 Sep 30, 2020
Q2 2020 -121 Apr 1, 2020 Jun 30, 2020
Q1 2020 69.8 Jan 1, 2020 Mar 31, 2020
Q4 2019 61.1 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.